Challenging times for FDA and drug companies equals IT opportunities
Even before the intense scrutiny that started in September when Vioxx’s manufacturer removed the drug from the market due to safety concerns, the U.S. Food and Drug Administration and the pharmaceutical industry faced a bumpy road....